Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 2

American Society of Hematology Publications

Is PFS the Right Endpoint to Assess Outcome of Maintenance Studies in Multiple Myeloma? Results of a Patient Survey Highlight Quality-of-Life As an Equally Important Outcome Measure | Blood | American Society of Hematology -

Abstract. Background: So far, planning of clinical trials in multiple myeloma (MM) has been based on traditional outcome measures such as progression free (PFS)

  • 123456 Profile photo of Madelyn
    Manni Mohyuddin

    We like to assume what patients want- but a substantial minority prefer PFS over QOL in the maintenance setting. Very thought provoking.

Read the full article here
See more from Manni Mohyuddin